NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Monday reported a loss of $5.9 million in its fourth quarter.
On a per-share basis, the New York-based company said it had a loss of 19 cents.
For the year, the company reported that its loss narrowed to $33.9 million, or $1.09 per share. Revenue was reported as $90,000.
In the final minutes of trading on Monday, the company’s shares hit 99 cents. A year ago, they were trading at $1.81.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
